Back
Las Vegas Sands Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
80
LVS
Las Vegas Sands
Last Price:
51.12
Seasonality Move:
4.03%
Sell
36
SRPT
Sarepta Therapeutics
Last Price:
124.65
Seasonality Move:
-1.39%
Buy
80
Las Vegas Sands (LVS)
is a Buy
Is Las Vegas Sands a Buy, Sell or Hold?
- The current Las Vegas Sands [LVS] share price is $51.12. The Score for LVS is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
- LVS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $124.53. The Score for SRPT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LVS Stock Price Chart
What is Las Vegas Sands's stock price today?
-
The Las Vegas Sands share price today is $51.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $124.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
LVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.9 | Buy |
| Relative Strength Index (14 RSI): | 86.14 | Buy |
| Chaikin Money Flow: | 10571647 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (38.29 - 44.23) | Buy |
| Bollinger Bands (100): | (39.6 - 45.2) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -3.18 | Sell |
| Relative Strength Index (14 RSI): | 35.54 | Sell |
| Chaikin Money Flow: | -49995 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.27 - 135.95) | Sell |
| Bollinger Bands (100): | (123.89 - 147.49) | Sell |
LVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 44.47 | Buy |
| 20-day SMA: | 41.63 | Buy |
| 50-day SMA: | 40.49 | Buy |
| 200-day SMA: | 46.41 | Buy |
| 8-day EMA: | 45.48 | Buy |
| 20-day EMA: | 42.83 | Buy |
| 50-day EMA: | 41.75 | Buy |
| 200-day EMA: | 45.09 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.45 | Sell |
| 20-day SMA: | 127.75 | Sell |
| 50-day SMA: | 135.2 | Sell |
| 200-day SMA: | 127.53 | Sell |
| 8-day EMA: | 125.39 | Sell |
| 20-day EMA: | 128.04 | Sell |
| 50-day EMA: | 132.59 | Sell |
| 200-day EMA: | 128.64 | Sell |
Las Vegas Sands Earnings Growth & LVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.18 per share, an increase this year of $0.56 per share, and an increase next year of $0.34 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.96 per share, an increase next quarter of $2.81 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Las Vegas Sands Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||